Efficacy and Tolerance of Anti–Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis - Normandie Université Access content directly
Journal Articles JAMA Dermatology Year : 2017

Efficacy and Tolerance of Anti–Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis

Valentine Heidelberger
  • Function : Author
Alicia Marquet
  • Function : Author
Didier Bessis
  • Function : Author
  • PersonId : 907533
Laurence Bouillet
Frédéric Caux
  • Function : Author
  • PersonId : 907535
Catherine Chapelon-Abric
  • Function : Author
  • PersonId : 900540
Olivier Fain
  • Function : Author
  • PersonId : 934441
Sylvain Marchand-Adam
  • Function : Author
  • PersonId : 989455
Nicolas Noel
Thierry Passeron
Denis Verrot
  • Function : Author
Pascal Sève

Abstract

Evidence for the long-term efficacy and safety of anti-tumor necrosis factor α agents (anti-TNF) in treating cutaneous sarcoidosis is lacking.

Dates and versions

hal-02377658 , version 1 (24-11-2019)

Identifiers

Cite

Valentine Heidelberger, Saskia Ingen-Housz-Oro, Alicia Marquet, Matthieu Mahevas, Didier Bessis, et al.. Efficacy and Tolerance of Anti–Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis. JAMA Dermatology, 2017, 153 (7), pp.681. ⟨10.1001/jamadermatol.2017.1162⟩. ⟨hal-02377658⟩
235 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More